AA
VMD icon

ALPS Advisors’s Viemed Healthcare VMD Stock Holding History

ALPS Advisors’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-31,893
Closed -$247K – 966
2020
Q4 		$247K Sell
31,893
-648
-2% -$5.7K ﹤0.01% 819
2020
Q3 		$281K Buy
+32,541
New +$328K ﹤0.01% 555

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ALPS Advisors's VMD Position: Q1 2021 in Review

ALPS Advisors sold out of Viemed Healthcare (VMD) in Q1 2021, closing a stake of 31,893 shares — an estimated $247K sold.

ALPS Advisors first reported a position in VMD in Q3 2020 and held it in 2 quarters. The position peaked at $281K in Q3 2020. 100 funds tracked by Wall St. Rank hold VMD as of Q1 2021.

  • ALPS Advisors reported no remaining Viemed Healthcare position as of Q1 2021 after selling out during the quarter.
  • ALPS Advisors sold 31,893 Viemed Healthcare shares in Q1 2021, an estimated $247K.
  • ALPS Advisors first reported a position in Viemed Healthcare in Q3 2020 and held it in 2 quarters.
  • ALPS Advisors's Viemed Healthcare position peaked at $281K in Q3 2020.
  • 100 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2021.

Based on ALPS Advisors's 13F filing for Q1 2021, filed 7 May 2021.